SCHEMBL5692015

SCHEMBL5692015

CC(C)c1cc(CC[Si](C)(C)c2ccccc2)cc(C(C)C)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 6/20 0.49
GABRB1 P18505 6/20 0.49
GABRB2 P47870 3/20 0.49
GABRA5 P31644 2/20 0.49
GABRA3 P34903 2/20 0.49
GABRA2 P47869 2/20 0.49
GABRA4 P48169 2/20 0.49
GABRA6 Q16445 2/20 0.49
TRPA1 O75762 1/20 0.47
GSR P00390 1/20 0.42
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
FAAH O00519 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5692375 0.80 PTGS1 (0.47) LMNAMAPTGAAHTTCYP1A2
SCHEMBL5693094 0.79 GABRA1 (0.45) GABRA1GABRB2TRPA1MAPTSMN1; SMN2
SCHEMBL5692077 0.79 GABRA1 (0.54) GABRA1GABRB1GABRB2GABRA5GABRA3
SCHEMBL9193416 0.79 GABRA1 (0.54) GABRA1GABRB1GABRB2GABRA5GABRA3
SCHEMBL27455835 0.78 GABRA1 (0.46) GABRA1GABRB1GABRB2GABRA5GABRA3
SCHEMBL27455331 0.77 GABRA1 (0.45) GABRA1GABRB1GABRB2GABRA5GABRA3
SCHEMBL7525520 0.77 TRPV1 (0.39) GABRA1GABRB1GABRB2TRPA1LMNA
SCHEMBL5692085 0.76 GAA (0.48) GSRLMNAMAPTGAAHTT
SCHEMBL5692097 0.76 ALOX5 (0.39) GABRA1GABRB2MAPTSMN1; SMN2NPC1
SCHEMBL6680818 0.76 PTGS1 (0.44) LMNAMAPTGAACYP1A2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1468692-B1 Use of 2,6-di-alkyl-4-silyl-phenols for treating xanthoma MERRELL PHARMA INC (US) 2006-04-26 EP disclosed
EP-0732928-B1 METHOD OF LOWERING SERUM CHOLESTEROL LEVELS WITH 2,6-DI-ALKYL-4-SILYL-PHENOLS MERRELL PHARMA INC (US) 2004-12-22 EP disclosed
EP-1468692-A2 Use of 2,6-di-alkyl-4-silyl-phenols for treating xanthoma MERRELL PHARMACEUTICALS INC. (US) 2004-10-20 EP disclosed
EP-1468693-A2 Use of 2,6-di -alkyl-4-silyl-phenols for treating diabetes mellitus MERRELL PHARMACEUTICALS INC. (US) 2004-10-20 EP disclosed
US-5795876-A ANTIINFLAMMATORY AGENTS HOECHST MARION ROUSSSEL, INC. (US) 1998-08-18 US disclosed
US-5532400-A 2,6-di-alkyl-4-silyl-phenols as antiatheroscelerotic agents MERRELL PHARMACEUTICALS INC. (US) 1996-07-02 US disclosed
EP-0464852-B1 Novel 2,6-di-alkyl-4-silyl-phenols as antiatherosclerotic agents and as antioxidants MERRELL DOW PHARMA (US) 1996-03-20 EP disclosed
US-5155250-A 2,6-DI-ALKYL-4-SILYL-PHENOLS AS ANTIATHEROSCEROTIC AGENTS MERRELL DOW PHARMACEUTICALS INC. (US) 1992-10-13 US disclosed
EP-0464852-A1 Novel 2,6-di-alkyl-4-silyl-phenols as antiatherosclerotic agents and as antioxidants MERRELL PHARMACEUTICALS INC. (US) 1992-01-08 EP disclosed